In our mid-year update on Healthcare Investments and Exits, we’re seeing a healthcare landscape that’s performed surprising well, against the backdrop of Covid-19 pandemic. Venture fundraising in healthcare soared to $10.4B in the first half of 2020, nearly matching 2019’s full-year record.

• Biopharma investments are up, led by large mezz deals IPO valuations and proceeds are on record pace and post-IPO stock performance has been incredible.
• Dx/Tools are on track for record investment, four IPOs boasted $1B+ market caps at mid-year Led by many companies leveraging their technologies to aid the COVID-19 response.
• HealthTech led post-IPO performance with a $2B+ IPO that then increased its stock price by over 100% Companies focused on providing alternative care outside the hospital raised 46% of capital in this sector.